OSC Directors's Message:
Elizabeth Wilder, Ph.D.
Director, Office of Strategic Coordination
Hello everyone, and welcome to the first issue of the NIH Common Fund Connection!
This will serve as a mechanism to inform the community about Common Fund research planning activities and funding announcements and to publicize research tools and data that are being made available through Common Fund programs. For example, researchers in the Common Fund’s Epigenomics program have created a new web-based browser for visualizing and interacting with whole genome epigenetic datasets. Sound useful? Check it out at http://epigenomegateway.wustl.edu/. We are also implementing other communications methods to keep you informed. We invite you to join our newly established Facebook Page (NIH Common Fund) and follow us on Twitter (@NIH_CommonFund) for information up to the minute. For the next few months, we will seek input on new Common Fund programs to begin in Fiscal Year 2013 or 2014. Check out the information below to learn how to make your opinions heard.
We in the Office of Strategic Coordination look forward to working more closely with all of you!
REQUEST FOR INFORMATION (RFI)
Defining Unmet Needs for Clinical Translation of Cell Based Therapies
The Common Fund’s NIH Center for Regenerative Medicine (NIH CRM) seeks comments on persistent unmet needs that currently impede technical and scientific progress in translating advances in stem and progenitor cell-based technologies to the clinic, and where NIH investment and/or coordination can help in overcoming these impediments.
View NOT-RM-12-008 or respond electronically here...
Disruptive Proteomics Technologies -
Challenges and Opportunities
As part of the initial planning phase, the DPT Working Group requests information on the following four topics related to needs/gaps/opportunities for NIH investment in both MS and non-MS-based disruptive proteomics technology development.
Read more about DPT here...
View NOT-RM-12-015 or respond electronically here...
"EMERGING OPPORTUNITIES FOR BIOMEDICAL RESEARCH"
How can the National Institutes of Health (NIH) accelerate progress in the most promising areas of science?
Your input is needed to identify areas where strategic investments by the NIH might accelerate the development of a nascent field or capitalize on a recent groundbreaking discovery.
NIH Common Fund Strategic Planning Meetings
Join us for two public regional meetings:
May 1- Chicago, IL May 3- San Francisco, CA
CONNECT WITH US ON EXOSOMES
We need your help exploring the possibility of developing a research program through the National Institutes of Health NIH Common Fund focusing on Exosomes/Microvesicles with the goal of accelerating basic and translational research in the exosome biology field.
FUNDING AT A GLANCE
| NIH Common Fund Program | Funding Opportunities Title | Receipt Date |
| MOLECULAR LIBRARIES | Assays for High Throughput Screening (HTS) to Discover Chemical Probes in-the Molecular Libraries Probe Production Centers Network (MLPCN) (X01) | 4/16/2012 |
| HCS RESEARCH COLLABORATORY | NIH Health Care Systems Research Collaboratory- Coordinating Center (U54) NIH Health Care Systems Research Collaboratory - Pragmatic Clinical Trials-Demonstration Projects (UH2/UH3) |
4/27/2012 5/02/2012 |
A Complete list of funding opportunities can be found on www.commonfund.nih.gov |
||
The National Institute of Health Common Fund produces The NIH Common Fund Connection to alert the scientific community to funding opportunities, trends and plans and to encourage input and feedback on activities. To subscribe, change your subscription options or unsubscribe, visit The NIH Common Fund Connection subscription page on the NIH LISTSERV Web site.